FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC ...Middle East

Iqirvo (elafibranor) is indicated for adults with primary biliary cholangitis who do not respond to or cannot tolerate ursodeoxycholic acid. Medscape Medical News

Hence then, the article about fda oks iqirvo first in class ppar treatment for pbc was published today ( Tuesday 11/06/2024 - 07:24 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC )

Also on site :

• After 100 years, the BBC still aspires to be the best of us – and if we take it for granted, we're fools
• Drew Barrymore’s ‘Charming’ New Under-$25 Sardine Home Collection at Walmart Is ‘Perfect for the Summertime’
• If Kombucha’s the New Tequila, What’s Next for Alcohol Brands?